CHO Pharma Financials
| 6586 Stock | TWD 55.70 0.40 0.72% |
CHO |
Understanding current and past CHO Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CHO Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in CHO Pharma's assets may result in an increase in income on the income statement.
The data published in CHO Pharma's official financial statements usually reflect CHO Pharma's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of CHO Pharma. For example, before you start analyzing numbers published by CHO accountants, it's critical to develop an understanding of what CHO Pharma's liquidity, profitability, and earnings quality are in the context of the CHO space in which it operates.
Please note, the presentation of CHO Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CHO Pharma's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in CHO Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of CHO Pharma. Please utilize our Beneish M Score to check the likelihood of CHO Pharma's management manipulating its earnings.
| Instrument | Taiwan Stock View All |
| Exchange | Taiwan OTC Exchange |
| Benchmark | NYSE Composite |
| Currency | TWD - New Taiwan Dollar |
You should never invest in CHO Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of CHO Stock, because this is throwing your money away. Analyzing the key information contained in CHO Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
CHO Pharma Key Financial Ratios
Generally speaking, CHO Pharma's financial ratios allow both analysts and investors to convert raw data from CHO Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of CHO Pharma over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CHO Pharma reports annually and quarterly.CHO Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CHO Pharma's current stock value. Our valuation model uses many indicators to compare CHO Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CHO Pharma competition to find correlations between indicators driving CHO Pharma's intrinsic value. More Info.CHO Pharma is rated below average in number of employees category among related companies. It is rated below average in market capitalization category among related companies creating about 494,545,455 of Market Capitalization per Number Of Employees. Comparative valuation analysis is a catch-all model that can be used if you cannot value CHO Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CHO Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CHO Pharma's earnings, one of the primary drivers of an investment's value.CHO Pharma Systematic Risk
CHO Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. CHO Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-five with a total number of output elements of thirty-six. The Beta measures systematic risk based on how returns on CHO Pharma correlated with the market. If Beta is less than 0 CHO Pharma generally moves in the opposite direction as compared to the market. If CHO Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one CHO Pharma is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of CHO Pharma is generally in the same direction as the market. If Beta > 1 CHO Pharma moves generally in the same direction as, but more than the movement of the benchmark.
About CHO Pharma Financials
What exactly are CHO Pharma Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include CHO Pharma's income statement, its balance sheet, and the statement of cash flows. Potential CHO Pharma investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although CHO Pharma investors may use each financial statement separately, they are all related. The changes in CHO Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CHO Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze CHO Pharma Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as CHO Pharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of CHO has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if CHO Pharma's financials are consistent with your investment objective using the following steps:- Review CHO Pharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand CHO Pharma's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare CHO Pharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if CHO Pharma's stock is overvalued or undervalued.
CHO Pharma April 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of CHO Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CHO Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of CHO Pharma based on widely used predictive technical indicators. In general, we focus on analyzing CHO Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CHO Pharma's daily price indicators and compare them against related drivers.
| Information Ratio | (0.13) | |||
| Maximum Drawdown | 14.33 | |||
| Value At Risk | (3.14) | |||
| Potential Upside | 3.82 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CHO Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for CHO Stock analysis
When running CHO Pharma's price analysis, check to measure CHO Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CHO Pharma is operating at the current time. Most of CHO Pharma's value examination focuses on studying past and present price action to predict the probability of CHO Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CHO Pharma's price. Additionally, you may evaluate how the addition of CHO Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |